Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Nanomaterials As Nanocarriers: A Critical Assessment Why These Are Multi-chore Vanquisher In Breast Cancer Treatment

Sania Naz, H. Shahzad, Attarad Ali, M. Zia
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract Breast cancer is a group of diseases with various subtypes and leads to high mortality throughout the globe. Various conventional techniques are in practice to cure breast cancer but these techniques are linked with various shortcomings. Mostly these treatments are not site directed and cause toxicity towards normal cells. In order to overcome these issues, we need smart system that can deliver anticancer drugs to specific sites. Targeted drug delivery can be achieved via passive or active drug delivery using nanocarriers. This mode of drug delivery is more effective against breast cancer and may help in the reduction of mortality rate. Potentially used nanocarriers for targeted drug delivery belong to organic and inorganic molecules. Various FDA approved nano products are in use to cure breast cancer. However, body’s defense system is main limitation for potential use of nano systems. However, this can be overcome by surface modification of nanocarriers. In this review, breast cancer and its types, targeted drug delivery and nanocarriers used to cure breast cancer are discussed. By progressing nanotechnology, we will be able to fight against this life threatening issue and serve the humanity, which is the basic aim of scientific knowledge.
This paper references
10.1039/C4EN00138A
Catalytic Properties and Biomedical Applications of Cerium Oxide Nanoparticles.
Carl D. Walkey (2015)
10.2147/NANO.2006.1.2.149
Immunonanoshells for targeted photothermal ablation of tumor cells
Amanda R. Lowery (2006)
10.1088/0957-4484/17/14/043
Synergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cells.
Renyun Zhang (2006)
10.1186/1756-9966-29-148
Antitumor activity of colloidal silver on MCF-7 human breast cancer cells
M. Franco-Molina (2010)
Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drugdelivery system. Nanoscale
N Tripathy (2015)
10.2147/IJN.S21697
Nickel nanowires induced and reactive oxygen species mediated apoptosis in human pancreatic adenocarcinoma cells
M. Hossain (2011)
10.1158/0008-5472.CAN-08-4698
Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.
M. Loebinger (2009)
10.1007/s11095-010-0233-4
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
C. Oerlemans (2010)
10.2174/1389450043345407
Drug delivery systems: past, present, and future.
R. Mainardes (2004)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
10.1016/S0140-6736(97)11423-4
Tamoxifen for early breast cancer: An overview of the randomised trials
O. Abe (1998)
Applications of Nanotechnology in Cancer: A literature Review on Imaging and Treatment
M. Bala (2017)
10.1002/jso.21698
The promise of nanotechnology for solving clinical problems in breast cancer
S. Grobmyer (2011)
10.1038/nbt1171
Designing dendrimers for biological applications
C. C. Lee (2005)
10.1146/annurev-med-040210-162544
Nanoparticle delivery of cancer drugs.
A. Wang (2012)
10.3109/1061186X.2012.712130
Nanoparticles-mediated drug delivery approaches for cancer targeting: a review
S. Sultana (2013)
10.3945/an.110.000232
Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.
S. Kelleher (2011)
10.1371/journal.pone.0035957
Arsenic Induces Functional Re-Expression of Estrogen Receptor α by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer
J. Du (2012)
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials
AK Gupta (2005)
10.1021/JM070280U
Basis for design and development of platinum(IV) anticancer complexes.
M. Hall (2007)
10.4143/crt.2009.41.1.1
Advances of cancer therapy by nanotechnology.
X. Wang (2009)
10.1021/BM7008203
Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells.
N. Stasko (2007)
10.1002/CHIN.200914224
Gold Nanocages: Synthesis, Properties, and Applications
S. Skrabalak (2009)
10.1002/tox.20704
Bio‐distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice
Suzanne Marie Hirst (2013)
10.1002/cncr.23836
Locally advanced breast cancer
N. E. El Saghir (2008)
Emerging Implications of Nanotechnology on Cancer Diagnostics and Therapeutics
Sumita Thakur (2012)
Controlling tumor growth by modulating endogenous production of reactive oxygen species.
A. Laurent (2005)
10.2147/OTT.S62057
Cerium oxide nanoparticles in cancer
Y. Gao (2014)
10.1038/nnano.2012.167
The nanomechanical signature of breast cancer.
M. Plodinec (2012)
10.2147/IJN.S25460
Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
Yan Chen (2011)
10.1021/nn200126a
Ce³+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles.
I. Celardo (2011)
10.2147/IJN.S16581
Zinc oxide nanoparticles as selective killers of proliferating cells
Liuba Taccola (2011)
10.2147/IJN.S18023
Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin
J. Wang (2011)
10.1016/J.BIOMATERIALS.2006.07.014
Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles.
F. Hu (2006)
10.1007/s12011-010-8707-0
Cellular Toxicity of TiO2 Nanoparticles in Anatase and Rutile Crystal Phase
Chan Jin (2010)
10.1016/j.toxlet.2009.07.009
PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes.
Rasmus Foldbjerg (2009)
10.1039/c4nr06979j
Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drug-delivery system.
N. Tripathy (2015)
10.3892/IJO.18.1.121
Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters.
T. Kubo (2001)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1016/j.tiv.2009.08.005
Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells.
Baher Fahmy (2009)
10.1038/onc.2014.282
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
Andrea L. Kasinski (2015)
10.1074/JBC.M211204200
A Novel Lytic Peptide Composed of dl-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice*
N. Papo (2003)
10.1016/J.NANO.2005.06.004
Role of nanotechnology in targeted drug delivery and imaging: a concise review.
O. Koo (2005)
10.1016/J.EURPOLYMJ.2015.01.016
Smart polymers in drug delivery systems on crossroads: Which way deserves following?
M. Hruby (2015)
10.1158/0008-5472.CAN-08-3845
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.
I. Ray-Coquard (2009)
10.2147/JBM.S29204
Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
A. Pai (2012)
10.1021/am100840c
Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier.
Pallab Sanpui (2011)
10.1002/EM.10062
Recent trends in breast cancer incidence and mortality
J. Lacey (2002)
10.1016/j.biomaterials.2010.01.057
Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy.
F. Dilnawaz (2010)
10.1002/pbc.25344
Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors
S. Akshintala (2015)
Plasma synthesis of carboniron magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery
Y Ma (2006)
10.1021/JP0516846
Anisotropic metal nanoparticles: Synthesis, assembly, and optical applications.
C. Murphy (2005)
10.1158/0008-5472.CAN-04-2550
Nanoparticle-Aptamer Bioconjugates
O. Farokhzad (2004)
10.1016/j.toxlet.2009.06.851
Engineered cobalt oxide nanoparticles readily enter cells.
E. Papis (2009)
10.1136/bmj.4.5733.486
Immunotherapy of cancer.
M. Woodruff (1970)
Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal goldrhTNF nanomedicine
SK Libutti (2010)
10.1021/ja105360z
Multiple release kinetics of targeted drug from gold nanorod embedded polyelectrolyte conjugates induced by near-infrared laser irradiation.
Tsung-Rong Kuo (2010)
10.1016/j.addr.2014.01.007
Ultrasound mediated transdermal drug delivery.
Aharon Azagury (2014)
10.1093/annonc/mdu025
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).
A. Awada (2014)
10.3322/canjclin.49.1.33
Global cancer statistics
D. Parkin (1999)
10.3390/ijms13089627
Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer
J. Xia (2012)
10.1016/j.bios.2010.09.057
Multifunctional DNA-based biomemory device consisting of ssDNA/Cu heterolayers.
Taek Lee (2011)
10.1002/EJOC.201500144
Synthesis and DNA‐Damaging Properties of Cisplatin‐N‐Mustard Conjugates
S. Schiesser (2015)
10.1021/CM051646Z
Development of Magnetic Nanostructured Silica-Based Materials as Potential Vectors for Drug-Delivery Applications
M. Arruebo (2006)
10.1002/anie.201400268
Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery.
Ran Mo (2014)
10.1016/j.addr.2012.11.006
Pharmacokinetic considerations for targeted drug delivery.
F. Yamashita (2013)
10.1016/j.jconrel.2008.05.010
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
10.2147/NSA.S99747
A role of ZnO nanoparticle electrostatic properties in cancer cell cytotoxicity
D. Wingett (2016)
10.1016/j.jconrel.2009.10.014
Size and shape effects in the biodistribution of intravascularly injected particles.
P. Decuzzi (2010)
10.1158/1078-0432.CCR-11-2938
Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
W. Zamboni (2012)
10.1023/A:1020398624602
Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor
A. Quintana (2004)
10.4172/2155-9619.1000195
Applications of Nanotechnology in Cancer: A Literature Review of Imaging and
A. Narayana (2014)
10.18632/oncotarget.8012
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors
J. Kopecka (2016)
10.1021/la903867a
Light-triggered liposomal release: membrane permeabilization by photodynamic action.
A. Pashkovskaya (2010)
10.6004/JNCCN.2011.0016
Invasive breast cancer.
I. Andersson (2011)
Functional repression of estrogen receptor a by arsenic trioxide in human breast cancer cells.
Gui-Cai Chen (2002)
10.1021/JP109819U
Direct Evidence for Hydroxyl Radical Scavenging Activity of Cerium Oxide Nanoparticles
Ying Xue (2011)
10.1038/sj.embor.7400705
Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions
I. Brockhausen (2006)
10.1021/IC0486419
Hydroxyl radical is the active species in photochemical DNA strand scission by bis(peroxo)vanadium(V) phenanthroline.
M. Sam (2004)
10.1002/JPS.2600681215
Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum.
P. Couvreur (1979)
10.1002/adma.201104797
Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles.
X. Yang (2012)
10.1021/ac3015164
Aptamer-guided silver-gold bimetallic nanostructures with highly active surface-enhanced Raman scattering for specific detection and near-infrared photothermal therapy of human breast cancer cells.
P. Wu (2012)
10.1039/c4dt02700k
Metal complex interactions with DNA.
Benjamin J Pages (2015)
10.1007/s11095-006-0284-8
Nanotechnology: Intelligent Design to Treat Complex Disease
P. Couvreur (2006)
[Breast carcinoma in men].
Daniel Sera (1988)
10.1038/srep11160
The footprint of urban heat island effect in China
Decheng Zhou (2015)
10.2147/IJN.S31133
Cuprous oxide nanoparticles selectively induce apoptosis of tumor cells
Y. Wang (2012)
10.1016/J.PROGPOLYMSCI.2005.06.005
Functional polymers: from plastic electronics to polymer-assisted therapeutics
J. Fréchet (2005)
10.1016/j.drudis.2012.05.010
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
P. Parhi (2012)
10.1016/j.jconrel.2008.06.004
Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes.
D. Auguste (2008)
10.1007/s12032-010-9552-x
Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide
X. Wang (2011)
10.1002/smll.201201141
Dendronized gold nanoparticles for siRNA delivery.
S. Kim (2012)
10.2217/nnm.11.30
Proinflammatory effects of bare and PEGylated ORMOSIL-, PLGA- and SUV-NPs on monocytes and PMNs and their modulation by f-MLP.
Daniela Segat (2011)
10.2174/092986709788803312
Doxorubicin: the good, the bad and the ugly effect.
C. Carvalho (2009)
10.1016/J.MATLET.2009.02.013
Effect of reducing agent on the synthesis of nickel nanoparticles
P. Khanna (2009)
10.1016/J.BIOS.2004.06.006
A novel glucose biosensor based on the nanoscaled cobalt phthalocyanine-glucose oxidase biocomposite.
K. Wang (2005)
Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine
J Colon (2010)
10.1088/0957-4484/19/29/295103
Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.
Cory Hanley (2008)
10.1016/0009-3084(93)90071-A
Liposomes: the Babraham connection.
A. Bangham (1993)
10.1007/BF03030694
Reactive oxygen species, antioxidants and signaling in plants
P. Ahmad (2009)
10.2147/IJN.S17595
Composite poly(vinyl alcohol)/poly(vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs
Marziyeh Jannesari (2011)
10.1007/s00204-010-0545-5
Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549
Rasmus Foldbjerg (2010)
10.1016/S1534-5807(04)00099-1
Development by self-digestion: molecular mechanisms and biological functions of autophagy.
B. Levine (2004)
10.1016/j.bmc.2014.05.030
DNA binders in clinical trials and chemotherapy.
Asfa Ali (2014)
10.1056/NEJMoa1109653
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
J. Baselga (2012)
10.1021/JP026731Y
The Optical Properties of Metal Nanoparticles: The Influence of Size, Shape, and Dielectric Environment
K. Kelly (2003)
10.1166/JNN.2006.469
Controlled drug delivery system based on magnetic hollow spheres/polyelectrolyte multilayer core-shell structure.
Y. Zhang (2006)
10.1021/mp100207t
Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
N. Chattopadhyay (2010)
10.1088/0953-8984/18/38/S24
Drug loaded magnetic nanoparticles for cancer therapy
R. Jurgons (2006)
10.4172/2157-7439.1000103E
Targeted Nanoparticles for Cancer Therapy: Promises and Challenges
K. Nguyen (2011)
10.1038/onc.2011.384
Molecular mechanisms of cisplatin resistance
L. Galluzzi (2012)
10.2165/00003495-200767090-00006
HER2-Positive Breast Cancer
Ryan H Engel (2012)
Emerging nanopharmaceuticals. Nanomed
WE Bawarski (2008)
10.1002/ANIE.200300602
Dendrimers in solution: insight from theory and simulation.
M. Ballauff (2004)
10.1021/acsami.5b01214
Synthesis of ultrastable copper sulfide nanoclusters via trapping the reaction intermediate: potential anticancer and antibacterial applications.
Hongyin Wang (2015)
10.1002/jps.22112
Targeted cancer therapy with novel high drug-loading nanocrystals.
F. Liu (2010)
10.1200/JCO.2013.54.2258
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.
H. Burstein (2014)
10.1043/1543-2165-133.4.611
Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines.
G. Vance (2009)
10.1016/J.MATLET.2006.10.067
Formation of NiS and CoS semiconductor nanoparticles inside mordenite-type zeolite
M. Sadjadi (2007)
10.1016/j.drudis.2010.01.009
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications.
A. R. Menjoge (2010)
10.1200/JCO.2004.08.181
Bone imaging in metastatic breast cancer.
T. Hamaoka (2004)
10.3109/02656736.2014.936049
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer
T. Zagar (2014)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
Liposomes : a practical approach
R. New (1990)
10.1007/s13277-015-4519-3
Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells
C. Biray Avci (2015)
10.1073/pnas.1016409108
Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets
N. Lee (2011)
10.1016/j.biomaterials.2012.10.013
Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases.
M. Malhotra (2013)
10.1007/s11095-005-2496-8
Lyophilized Paclitaxel Magnetoliposomes as a Potential Drug Delivery System for Breast Carcinoma via Parenteral Administration: In Vitro and in Vivo Studies
J. Zhang (2005)
10.1007/s12645-013-0042-7
Surface modification of cobalt oxide nanoparticles using phosphonomethyl iminodiacetic acid followed by folic acid: a biocompatible vehicle for targeted anticancer drug delivery
S. Chattopadhyay (2013)
10.1155/2012/751075
Noble Metal Nanoparticles Applications in Cancer
João Conde (2012)
10.1093/jnci/djn324
Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
B. Takkouche (2008)
10.1136/bmj.2.5711.735
Early breast cancer.
B. M. Truscott (1970)
10.1021/nn202966t
Molecular responses of human lung epithelial cells to the toxicity of copper oxide nanoparticles inferred from whole genome expression analysis.
N. Hanagata (2011)
10.1016/j.ijbiomac.2014.01.054
Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a "smart" drug delivery system to breast cancer cell therapy.
R. Vivek (2014)
10.1021/ar800150g
Nanoshell-enabled photothermal cancer therapy: impending clinical impact.
Surbhi Lal (2008)
10.1002/smll.201403232
Mechanistic Investigation of the Biological Effects of SiO₂, TiO₂, and ZnO Nanoparticles on Intestinal Cells.
M. I. Setyawati (2015)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.1016/j.nano.2008.06.002
Emerging nanopharmaceuticals.
Willie E. Bawarski (2008)
10.1021/ja4124412
Enhancing the efficiency of gold nanoparticles treatment of cancer by increasing their rate of endocytosis and cell accumulation using rifampicin.
Moustafa R K Ali (2014)
10.1016/j.ijpharm.2009.10.018
Polymer-based nanocapsules for drug delivery.
C. E. Mora-Huertas (2010)
10.1088/1748-6041/4/2/025013
Study on the enhanced cellular uptake effect of daunorubicin on leukemia cells mediated via functionalized nickel nanoparticles.
Dadong Guo (2009)
10.1016/J.EJPB.2004.06.009
Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation.
J. Zhang (2005)
10.1007/S00216-005-0247-7
Nano-oncology: drug delivery, imaging, and sensing
N. G. Portney (2006)
10.1021/mp800022a
Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.
C. Boswell (2008)
10.1080/10611860400010655
Solubility Enhancement of Indomethacin with Poly(amidoamine) Dendrimers and Targeting to Inflammatory Regions of Arthritic Rats
A. Chauhan (2004)
Nanoparticleaptamer bioconjugates a new approach for targeting prostate cancer cells
OC Farokhzad (2004)
10.1073/pnas.2232479100
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
L. R. Hirsch (2003)
10.2217/17435889.1.3.297
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
M. Immordino (2006)
10.1021/ar200023x
Theranostic nanoshells: from probe design to imaging and treatment of cancer.
R. Bardhan (2011)
10.1038/263797A0
Polymers for the sustained release of proteins and other macromolecules
R. Langer (1976)
10.1021/nn102762f
Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy.
Charles Sanson (2011)
Antibacterial and anticancer properties of NiO nanoparticles by co-precipitation method
L. Umaralikhan (2016)
Biodegradable longcirculating polymeric nanospheres
R Gref (1994)
10.1039/B309043B
Dendrimers in drug research.
U. Boas (2004)
10.1158/0008-5472.CAN-15-1286
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.
Susan F Murphy (2016)
10.1006/GYNO.2000.6003
Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
R. Goshen (2000)
10.1002/jcb.20102
Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells
S. K. Chow (2004)
10.1021/ja304180y
TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance.
Hsiangkuo Yuan (2012)
10.1016/j.ejmp.2016.03.014
Potential of using cerium oxide nanoparticles for protecting healthy tissue during accelerated partial breast irradiation (APBI).
Z. Ouyang (2016)
10.1002/SMLL.200600056
Carbon nanotube-DNA nanoarchitectures and electronic functionality.
X. Wang (2006)
10.1016/j.jconrel.2012.01.023
Evaluation of selective tumor detection by clinical magnetic resonance imaging using antibody-conjugated superparamagnetic iron oxide.
Takayoshi Koyama (2012)
10.1136/bmj.1.5850.372
Locally advanced breast cancer.
F. Esteva (1999)
10.1016/j.colsurfb.2009.09.001
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
10.1038/nrclinonc.2009.166
Histological and molecular types of breast cancer: is there a unifying taxonomy?
B. Weigelt (2009)
10.1211/jpp.60.6.0001
Tumour and dendrimers: a review on drug delivery aspects
A. Agarwal (2008)
10.1259/bjr/59448833
Gold nanoparticles as novel agents for cancer therapy.
S. Jain (2012)
10.1039/C4RA12163E
Understanding the pathway of antibacterial activity of copper oxide nanoparticles
S. Meghana (2015)
10.2165/00003088-200342050-00002
Pharmacokinetics of Pegylated Liposomal Doxorubicin
A. Gabizon (2003)
10.1007/s00280-003-0719-4
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma
W. Zamboni (2003)
10.1002/ADFM.201201663
Gold Nanoshell Nanomicelles for Potential Magnetic Resonance Imaging, Light‐Triggered Drug Release, and Photothermal Therapy
Y. Ma (2013)
10.1038/nm1467
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
10.6092/1590-8577/2507
MM-398 achieves primary endpoint of overall survival in phase III study in patients with gemcitabine refractory metastatic pancreatic cancer.
M. Saif (2014)
10.1016/J.JCONREL.2004.06.009
A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
M. Hussain (2004)
10.1124/JPET.102.042176
Blockage of Multidrug Resistance-Associated Proteins Potentiates the Inhibitory Effects of Arsenic Trioxide on CYP1A1 Induction by Polycyclic Aromatic Hydrocarbons
L. Vernhet (2003)
10.3892/ETM.2011.224
Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels.
Y. Wang (2011)
10.1016/S0140-6736(97)11423-4
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group (1998)
10.1016/j.drudis.2010.08.006
Cancer nanotechnology: application of nanotechnology in cancer therapy.
R. Misra (2010)
10.1002/jat.1609
Nanotechnology and human health: risks and benefits
A. G. Cattaneo (2010)
10.1021/nn100816s
Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles.
Atul Asati (2010)
10.1021/ja8050469
Redox-triggered contents release from liposomes.
W. Ong (2008)
10.1016/j.nano.2010.01.010
Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2.
J. Colon (2010)
10.1016/J.CANLET.2005.07.035
Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.
I. El-Sayed (2006)
10.1002/smll.201402149
Controlled synthesis of multilayered gold nanoshells for enhanced photothermal therapy and SERS detection.
Yongping Gao (2015)
10.1021/bc500545z
Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle.
Paul L Chariou (2015)
10.1016/j.ijpharm.2009.12.061
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.
M. Krieger (2010)
10.1007/s11671-009-9413-8
The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction
Cory Hanley (2009)
10.1021/ja905938a
FePt nanoparticles as an Fe reservoir for controlled Fe release and tumor inhibition.
C. Xu (2009)
10.1155/2013/623497
Evaluation of the antitumor activity by Ni nanoparticles with verbascoside
Mingyue Chen (2013)
10.1166/JBN.2016.2214
Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth.
G. Salzano (2016)
10.1155/2011/414729
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Fatemeh Madani (2011)
10.1200/JCO.2009.26.3756
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
H. Burstein (2010)
10.1039/c2cc33543c
pH-responsive NIR enhanced drug release from gold nanocages possesses high potency against cancer cells.
P. Shi (2012)
10.1053/SHEM.2002.33610
Arsenic trioxide: mechanisms of action.
K. Davison (2002)
10.1021/AR040204A
Mechanisms of protein assembly: lessons from minimalist models.
Y. Levy (2006)
10.1038/srep11518
Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis Theranostics
C. Zhao (2015)
10.1146/ANNUREV.BIOENG.9.060906.152025
Nanotechnology applications in cancer.
Shuming Nie (2007)
10.1007/s11095-008-9800-3
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
C. Vauthier (2008)
10.1016/j.bbagen.2013.08.011
Interplay between autophagy and apoptosis mediated by copper oxide nanoparticles in human breast cancer cells MCF7.
Dipranjan Laha (2014)
10.1021/MP0500014
Iron oxide nanoparticles for sustained delivery of anticancer agents.
Tapan Jain (2005)
10.1155/2013/535796
Cytotoxicity of Biologically Synthesized Silver Nanoparticles in MDA-MB-231 Human Breast Cancer Cells
S. Gurunathan (2013)
10.1361/105994906X113705
Plasma synthesis of carbon-iron magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery
Y. Ma (2004)
10.1093/annonc/mdu025
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).
A. Awada (2014)
10.1021/NL061025K
Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm.
T. Xia (2006)
10.2165/00003088-200847100-00001
Disposition of Drugs in Block Copolymer Micelle Delivery Systems
H. M. Aliabadi (2008)
10.1016/j.jconrel.2012.07.010
Analysis on the current status of targeted drug delivery to tumors.
I. Kwon (2012)
10.1016/j.blre.2010.04.001
Arsenic trioxide - An old drug rediscovered.
A. Emadi (2010)
10.1177/153537020322800903
Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System
Rebecca Simstein (2003)
10.1038/cddis.2013.207
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
K. Kono (2013)
10.1016/J.AUTREV.2014.10.002
Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.
M. Dwivedi (2015)
10.2147/IJN.S29129
Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species
M. Akhtar (2012)
10.1073/pnas.0711714105
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
F. Gu (2008)
10.1158/1078-0432.CCR-10-0978
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
S. Libutti (2010)
10.1007/s10856-010-3998-4
In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery
S. Sahu (2010)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.1038/leu.2011.245
Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
E. Lengfelder (2012)
10.6004/JNCCN.2011.0016
Invasive breast cancer.
R. Carlson (2011)
10.1021/ic500001j
C1-symmetrical titanium(IV) complexes of salan ligands with differently substituted aromatic rings: enhanced cytotoxic activity.
H. Glasner (2014)
10.1038/AM.2013.88
Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications
C. Xu (2014)
10.1007/s10544-008-9209-0
Nanotechnology for breast cancer therapy
T. Tanaka (2009)
10.1021/ja8086906
Synthesis of uniform ferrimagnetic magnetite nanocubes.
D. Kim (2009)
10.1021/ED009P1751
The discovery of the elements. XVI. The rare earth elements
M. E. Weeks (1932)
10.1016/j.toxlet.2008.04.015
The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells.
Yi-Hong Hsin (2008)
Ce3þ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles
I Celardo (2011)
10.1002/CHIN.200718202
FePt@CoS2 Yolk—Shell Nanocrystals as a Potent Agent to Kill HeLa Cells.
J. Gao (2007)
10.1038/sj.clpt.6100400
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
10.2147/IJN.S11727
Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model
Muthu Irulappan Sriram (2010)
10.1016/j.jconrel.2009.10.002
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
P. Pradhan (2010)
10.1021/NL050127S
Immunotargeted nanoshells for integrated cancer imaging and therapy.
C. Loo (2005)
10.1007/s002800000177
Phase I study of liposomal annamycin
D. Booser (2000)
10.1016/j.radonc.2011.07.020
Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial.
D. Kauer-Dorner (2012)
10.1002/JPS.21155
Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system.
Weilun Ke (2008)
10.1021/CR030698+
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology.
M. Daniel (2004)
10.1080/02652040500435444
Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics
J. Yang (2006)
10.1097/01.CAD.0000167902.53039.5A
Liposomal encapsulated anti-cancer drugs.
R. Hofheinz (2005)
10.1021/ACSBIOMATERIALS.6B00333
Size and Chemistry Controlled Cobalt-Ferrite Nanoparticles and Their Anti-proliferative Effect against the MCF-7 Breast Cancer Cells
S. Ansari (2016)
10.1074/jbc.272.41.25968
Gp60 Activation Mediates Albumin Transcytosis in Endothelial Cells by Tyrosine Kinase-dependent Pathway*
C. Tiruppathì (1997)
10.1016/S0140-6736(16)32417-5
HER2-positive breast cancer
S. Loibl (2017)
10.1148/radiol.12110748
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
N. Hylton (2012)
10.1073/pnas.0813019106
Picomolar sensitivity MRI and photoacoustic imaging of cobalt nanoparticles
L. Bouchard (2009)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1111/cpr.12005
Identification of novel caspase/autophagy‐related gene switch to cell fate decisions in breast cancers
L-L Fu (2013)
10.1021/ja900790v
Dumbbell-like Au-Fe3O4 nanoparticles for target-specific platin delivery.
C. Xu (2009)
10.2147/OTT.S58044
Nickel nanoparticle-induced dose-dependent cyto-genotoxicity in human breast carcinoma MCF-7 cells
M. Ahamed (2014)
10.1158/1535-7163.MCT-06-0141
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Rajni Sinha (2006)
10.1016/j.chemphyslip.2009.08.003
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Avi Schroeder (2009)
10.1089/HYB.1997.16.109
Applications of magnetic targeting in diagnosis and therapy--possibilities and limitations: a mini-review.
W. Schuett (1997)
10.1155/2012/581363
Lipoplatin Formulation Review Article
G. Stathopoulos (2012)
10.1038/nrc1566
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
10.1016/j.colsurfb.2012.02.039
The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells.
Prachi Joshi (2012)
10.1016/j.ejpb.2008.09.026
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.
V. Torchilin (2009)
Dendrimer grafts for delivery of 5-fluorouracil.
P. Tripathi (2002)
Tshuva EY. C 1-Symmetrical Titanium (IV) Complexes of Salan Ligands with Differently Substituted Aromatic Rings: Enhanced Cytotoxic Activity
H Glasner (2014)
10.1007/S10254-004-0024-6
Pharmacological properties of cerium compounds.
M. Jakupec (2005)
10.1016/j.tibs.2010.04.002
Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes.
R. Hamanaka (2010)
10.1016/j.drup.2011.01.003
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Alina Shapira (2011)
10.2217/17435889.3.6.831
Optimizing magnetic nanoparticle design for nanothermotherapy.
F. Gazeau (2008)
10.1016/0014-5793(81)80071-3
The Hydrophobic Effect: Formation of Micelles and Biological Membranes
C. Walker (1981)
10.1021/nn4011686
Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy.
J. Lin (2013)
10.1146/ANNUREV.PHYSCHEM.54.011002.103759
Optical properties and ultrafast dynamics of metallic nanocrystals.
S. Link (2003)
10.1038/nnano.2007.387
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar